Skip to content

EMEUNEWS

Search
  • Congress Topics
    • Basic Research
    • Imaging
    • Metabolic and Crystal Arthropathies
    • Paediatric Rheumatology
    • Rare and Autoinflammatory Diseases
    • Rheumatoid Arthritis I – Clinical (non-therapeutic)
    • Rheumatoid arthritis II – therapeutic
    • Spondyloarthritis I – non-therapeutic
    • Spondyloarthritis II – therapeutic
  • Featured Content
  • Press Review
    • Annals of the Rheumatic Diseases
    • RMD Open
    • Arthritis and Rheumatology
    • Rheumatology (Oxford)
    • Arthritis Research and Therapy
    • Arthritis Care and Research
    • Seminars in Arthritis and Rheumatism
    • The Lancet Rheumatology
    • Miscellaneous
  • About EMEUNEWS
  • About EMEUNET
  • Contact Us
  • Subscribe here!

Tag: Activities

EMEUNET SUB-COMMITTEES

EMEUNET Sub-Committees and Activities 2025 – Peer Mentoring Sub-Committee

6 Mar 2025
The Peer Mentoring Sub-Committee aims to provide support, guidance and mentorship to young clinical or research fellows in rheumatology. It also encourages the exchange of ideas and networking between peers…
EMEUNET SUB-COMMITTEES

EMEUNET Sub-Committees and Activities 2025 – Visibility and Global Affairs Sub-Committee

6 Mar 2025
The main objective of the V&GA subcommittee is to enhance global awareness of EMEUNET as an organisation and the projects we undertake. The goals of the subcommittee include:​ Increasing EMEUNET visibility among young rheumatologists and…
EMEUNET SUB-COMMITTEES

Country Liaison National Promotional Activities

13 Apr 2024
The CLs contribute and support promotional activities in their local organisations. This collaborative effort aims to promote the visibility of EMEUNET and its initiatives, fostering engagement at the local level. Logistical support is…
EMEUNET SUB-COMMITTEES

EMEUNET Country Liaison Meeting at EULAR Congress

13 Apr 2024
The Country Liaison Sub-committee has organised the Country Liaison meeting annually during the EULAR Congress since 2014.  This provides a valuable opportunity for CLs to connect, share their work, discuss challenges faced…
EMEUNET Committee and Sub-Commitee

EMEUNET Sub-Committees and Activities 2024 – Chairmanship

28 Feb 20241 Mar 2024
  EMEUNET is the largest network of early career clinicians and researchers in the field of rheumatology. The main objectives of EMEUNET are to promote top quality education and mentoring…
EMEUNET SUB-COMMITTEES

EMEUNET Sub-Committees and Activities 2024 – Country Liaison Sub-Committee

28 Feb 2024
  The Country Liaison Sub-Committee serves as a crucial link and bridge between the EULAR|EMEUNET Committee and the Country Liaisons (CLs), who act as our representatives at the national level. Our primary…
EMEUNET SUB-COMMITTEES

EMEUNET Sub-Committees and Activities 2024 – Peer Mentoring Sub-Committee

28 Feb 202428 Feb 2024
The Peer Mentoring Sub-Committee aims to provide support, guidance and mentorship to young clinical or research fellows in rheumatology. It also encourages the exchange of ideas and networking between peers…
EMEUNET SUB-COMMITTEES

EMEUNET Sub-Committees and Activities 2024 – Visibility and Global Affairs Sub-Committee

28 Feb 202428 Feb 2024
The main objective of the V&GA subcommittee is to enhance global awareness of EMEUNET as an organization and the projects we undertake. The goals of the subcommittee include:​ Increasing EMEUNET visibility among young rheumatologists and…

Posts navigation

Newer posts

Seestrasse 240
CH 8802 Kilchberg (ZH)
Switzerland
emeunet@eular.ch
emeunet.eular.org

About EULAR
The European Alliance of Associations for Rheumatology, EULAR, is the organisation which represents the people with arthritis/rheumatism, health professionals in rheumatology (HPR) and scientific societies of rheumatology of all the European nations.
Visit website here

About EMEUNET
EMEUNET is an exciting community that started its activities in 2009, emanating from one of the objectives set by EULAR – "Bring on board high quality, young generation contributors in all EULAR activities".
Visit website here

  • Facebook
  • Twitter
  • Instagram
  • YouTube
  • Spotify

Loading Comments...